ENCePP web header
ENCePP web header

  • Ruthsarian
  • Home
  • Sitemap
  • Q & A
  • Notice Board
    • PhEpi & PhV activities
    • Research Funding
    • Conferences & meetings
    • Recruitment
  • Links
  • Contact Us

Links to Studies

Status Official Title Lead Investigator Last Updated
Finalised Comparative study of COPD double therapy versus triple therapy: an EGB data analysis Dr Eric VAN GANSE 11/12/2018
Finalised Observational study to quantify in real life the contribution of SINGULAIR ® 4mg in children aged from 6 to 24 months Dr Eric VAN GANSE 20/06/2017
Finalised Study of healthcare consumption of patients over 45 years with chronic Chronic Obstructive Pulmonary Disease Dr Eric VAN GANSE 20/06/2017
Finalised Annual investigate of EMEND prescription Dr Eric VAN GANSE 20/06/2017
Finalised Observational study of the persistence antiglaucoma eyedrops to Dr Eric VAN GANSE 20/06/2017
Finalised Comparison of care use between cohorts differentiated by the patients adherence to statins in France between 2005 and 2008 Dr Eric VAN GANSE 21/09/2016
Finalised Study of the impact of non-compliance with GINA recommendations on the care consumption of adult asthmatic patient Dr Eric VAN GANSE 21/09/2016
Finalised Assessment of the safety of LABAs in asthma in routine care by combining healthcare databases and direct patient follow-up Dr Eric VAN GANSE 29/07/2016


  • News
  • About Us
  • ENCePP Documents
  • Training in PhEpi and PV

  • Code of Conduct
  • Standards & Guidances
  • ENCePP Study Seal
  • Public Consultation
  • Glossary of terms

  • Resources Database

  • Partners forum

  • EU PAS Register

  • About EU PAS Register

© 1995-2020 European Medicines Agency | Contact Us | Privacy Policy | Admin Login | Disclaimer

As of 1.2.2020, the UK is no longer an EU Member State. However, EU law still applies to the UK during the transition period.


combined emea eu logo European Medicines Agency Europa Website
Version: 4.4.1.1